Updated on 18 August 2026
Power Paint
COO at XC Coatings
China (Hong Kong)
About
赫利塗料科技有限公司(XC Coatings)是专注绿色能源塗料的高新科技企业,总部位于广州,并布局香港与宁波。公司拥有自主实用新型专利「一种改进型发电油漆涂层」,核心产品包括全天候紫外线发电塗料、高效隔热保温塗料及锂电池陶瓷化安全涂层。技术源自产学研合作,已获香港民青局辖下明汇智库的港币45万元资助,并完成专利入资评估。
Project Location
- China (Hong Kong)
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- Yes
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Technology
Energy and Natural Resources
- Solar Energy
Technology
- Environmental Technology
Total Project Value
- 2,500,001 to 5,000,000 USD
Investment Capital Required
- 1,000,001 to 2,500,000 USD
Interested Format of Cooperation
- Equal Shareholdings
- Minority Shareholdings
Preferred Financing Model
- Equity
- Open for negotiation
Type(s) of Last Financing Round of the project (if Applicable)
- Government & Public Funding
Total amount raised (USD)
55000
Return on Investment
32
Main Service(s) Required
- Environmental Services
Environmental Services
- Green Building Solutions & Services
Financial Services
- Institutional Investment
Information Technology Services
- Risk Management (ITS)
Infrastructure Services
- Construction Engineering
- Infrastructure & Town Planning
Professional Services
- IP Related
Attached files
Organisation
China (Hong Kong)
Similar opportunities
Project
- No
- Yes
- Technology
- Operations
- Manufacturing
- Bootstrapping
- Biomass Energy
- Energy Storage
- Private Project
- Energy Management
- Power Transmission
- Resource Recycling
- Corporate Services
- Professional Services
- Other Renewable Energy
- Environmental Services
- Intelligent Manufacturing
- Import & Export Solutions
- Energy and Natural Resources
- 10,000,001 to 25,000,000 USD
- Information Technology Services
晓红 赵
总裁 at 哈尔滨九洲集团股份有限公司
China
Project
通用型人类多能干细胞来源胰岛类器官糖尿病根治性疗法 (Off-the-shelf Stem Cell-derived Islet Organoid Therapy for Diabetes Cure)
- No
- Yes
- Equity
- Technology
- Equity (private)
- Financial Services
- Professional Services
- Minority Shareholdings
- Direct Equity Investment
- 25,000,001 to 50,000,000 USD
- 25,000,001 to 50,000,000 USD
- Investment / Financing Discussion
- Public-Private Partnership Project
Yi HE
CTO at 周易生物
China (Hong Kong)
Project
通用型人类多能干细胞来源胰岛类器官糖尿病根治性疗法 (Off-the-shelf Stem Cell-derived Islet Organoid Therapy for Diabetes Cure)
- No
- Yes
- Equity
- Bio-Tech
- Technology
- IP Related
- Legal Advisory
- Equity (private)
- Medical Technology
- Financial Services
- Financial Advisory
- Professional Services
- Minority Shareholdings
- Corporate Intelligence
- Direct Equity Investment
- Institutional Investment
- 2,500,001 to 5,000,000 USD
- 25,000,001 to 50,000,000 USD
- Private Equity & Venture Capital
- Investment / Financing Discussion
- Public-Private Partnership Project
彬 杨
CEO at 周易生物
China (Hong Kong)